Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Scancell signs agreement with NIH for SCIB-1 melanoma vaccine components

May 12, 2010

Swedish Orphan Biovitrum and Biomodels enter agreement to develop mucositis risk assay

May 12, 2010

Ferring acquires global rights to Lysteda from Xanodyne

May 12, 2010

Shionogi transfers sales rights of Avelox to Bayer Healthcare

May 12, 2010

Acrux and Vivus sign settlement agreement for Luramist dispute, Vivus license terminated

May 11, 2010

Takeda and Janssen Pharmaceutical agree to copromote Velcade in Japan

May 11, 2010

MediGene signs license agreements with GC-Rise and JS Bio for Veregen

May 11, 2010

Evotec and Genentech enter agreement to discover small-molecule therapeutics

May 11, 2010

Alzheimer's Drug Discovery Foundation funds chaperone technology

May 10, 2010

Meda acquires exclusive rights to flupirtine for fibromyalgia

May 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...